Sofia Touami reports a stock award at Lycia Therapeutics
By AlphaYouPublished Form 4
Touami Sofia
Reporting filer
Sofia Touami reports a stock award, not an open-market purchase or sale, in Lycia Therapeutics, Inc.. Form 4 filed Oct 26, 2026 lists 1 entry.
- Disclosed
- Oct 26, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) (derivative) | Touami Sofia | 2026-08-11 | A | Grant or award | 68755 | 0 | 68,755 | 76 days | Filed terms
|
Stock Option (Right to Buy) (derivative)
- Owner
- Touami Sofia
- Date
- 2026-08-11
- Code
- A
- Action
- Grant or award
- Quantity
- 68755
- Price
- 0
- Following holdings
- 68,755
- Reporting delay
- 76 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 3.70
- transaction Date: 2026-08-11
- id: F1
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 68755
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F2
- expiration Date: 2036-08-10
- underlying Security Title: Common Stock
- underlying Security Shares: 68755
- shares Owned Following Transaction: 68755
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Touami Sofia: Chief Business Officer.
- F1: The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Exchange Act in connection with the Issuer's initial public offering, and the transaction is reported herein pursuant to Rule 16a-2(a).
- F2: The options vest as to 1/48 of the total award monthly over four years, with the first tranche vested on September 6, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.